Skip to main content
Equibles

FMR LLC

Position in NEO — Neogenomics Inc

CIK 315066 BOSTON, MA
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,416,248
+$1,737,006 QoQ
Shares Held
234,150
+3.5% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

FMR LLC holds $20,923,751,494 across 34 Diagnostics & Research names. NEO ranks #23 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 14,084,488 $7,061,398,899
2 DHR
Danaher Corp /De/
 29,540,895 $5,626,949,677
3 NTRA
Natera, Inc.
 5,451,396 $1,479,781,442
4 CRL
Charles River Laboratories International, Inc.
 4,239,752 $961,533,354
5 ICLR
Icon PLC
 5,271,321 $915,681,168
6 GH
Guardant Health, Inc.
 5,488,272 $823,405,446
7 ILMN
Illumina, Inc.
 4,523,417 $795,352,409
8 A
Agilent Technologies, Inc.
 5,076,167 $674,267,260

All Filings in NEO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,416,248 234,150
2026-03-31 $1,679,242 226,313
2025-12-31 $2,004,926 170,487
2025-09-30 $286,628 37,128
2025-06-30 $1,128,451 154,371
2025-03-31 $78,433 8,265
2024-12-31 $425,397 25,813
2024-09-30 $195,510 13,255
2024-06-30 $170,932 12,324
2024-03-31 $239,194 15,216
2023-12-31 $235,467 14,553
2023-09-30 $99,777 8,112
2023-06-30 $137,735 8,571
2023-03-31 $161,894 9,299
2022-12-31 $72,958 7,896
2022-09-30 $122,614 14,241
2022-06-30 $87,375 10,721
2022-03-31 $27,020 2,224
2021-12-31 $64,384 1,887
2021-09-30 $99,615 2,065
2021-06-30 $49,325 1,092
2021-03-31 $50,641 1,050
2020-12-31 $76,021 1,412
2020-09-30 $86,432 2,343
2020-06-30 $38,073 1,229
2020-03-31 $26,698 967